Effect of high-dose 1.25 dihydroxyvitamin D3on remyelination in the cuprizone model

Vitamin D and multiple sclerosis

(2013) Sarah Hewer et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Expression of Vitamin D Receptor and Metabolizing Enzymes in Multiple Sclerosis—Affected Brain Tissue

(2013) Joost Smolders et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes

(2013) Karelle Bénardais et al.   NEUROTOXICITY RESEARCH

A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)

(2012) M. Pugliatti et al.   ACTA NEUROLOGICA SCANDINAVICA

Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination

(2012) Wolfgang Brück et al.   ACTA NEUROPATHOLOGICA

Vitamin D and multiple sclerosis

(2012) Kelly C. Simon et al.   CURRENT OPINION IN NEUROLOGY

Vitamin D in multiple sclerosis: implications for assessment and treatment

(2012) Trygve Holmøy et al.   Expert Review of Neurotherapeutics

Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination

(2012) J. P. Buschmann et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Vitamin D and disease activity in multiple sclerosis before and during interferon-  treatment

(2012) K. I. Loken-Amsrud et al.   NEUROLOGY

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

(2012) Jan Dörr et al.   Trials

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis

(2011) M. S. Stein et al.   NEUROLOGY

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model

(2011) Stig Wergeland et al.   PLoS One

The cuprizone animal model: new insights into an old story

(2009) Markus Kipp et al.   ACTA NEUROPATHOLOGICA

Vitamin D treatment in multiple sclerosis

(2009) Kjell-Morten Myhr   JOURNAL OF THE NEUROLOGICAL SCIENCES

Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination

(2009) Maren Lindner et al.   NEUROSCIENCE LETTERS

Astrocytes in multiple sclerosis: A product of their environment

(2008) A. Nair et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Vitamin D as an immune modulator in multiple sclerosis, a review

(2008) Joost Smolders et al.   JOURNAL OF NEUROIMMUNOLOGY

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET